ProfileGDS4718 / 204938_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 9% 16% 95% 10% 12% 9% 8% 9% 23% 11% 12% 14% 7% 14% 10% 41% 21% 13% 8% 16% 11% 13% 20% 11% 14% 12% 29% 13% 17% 10% 9% 66% 10% 8% 45% 16% 12% 11% 9% 95% 13% 11% 64% 6% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.773649
GSM549102patient 115, normal, homogenized [OPG study]4.0196816
GSM549104patient 119, normal, homogenized [OPG study]10.388895
GSM549108patient 138, normal, homogenized [OPG study]3.8179910
GSM549119patient 077, normal, homogenized [OPG study]3.8422612
GSM549133patient 032, cancer, homogenized [OPG study]3.720379
GSM549139patient 042, cancer, homogenized [OPG study]3.701398
GSM549099patient 107, normal, homogenized [OPG study]3.735199
GSM549109patient 139, normal, homogenized [OPG study]4.2798223
GSM549110patient 046, normal, homogenized [OPG study]3.8347611
GSM549114patient 063, normal, homogenized [OPG study]3.8338112
GSM549122patient 082, normal, homogenized [OPG study]3.9520714
GSM549134patient 033, cancer, homogenized [OPG study]3.657887
GSM549136patient 036, cancer, homogenized [OPG study]3.8881914
GSM549140patient 044, cancer, homogenized [OPG study]3.7507710
GSM549111patient 047, normal, homogenized [OPG study]5.0302341
GSM549113patient 057, normal, homogenized [OPG study]4.144821
GSM549132patient 031, cancer, homogenized [OPG study]3.8895313
GSM549137patient 038, cancer, homogenized [OPG study]3.69798
GSM549142patient 047, cancer, homogenized [OPG study]4.0663216
GSM549100patient 110, normal, homogenized [OPG study]3.7988311
GSM549107patient 135, normal, homogenized [OPG study]3.8565913
GSM549115patient 068, normal, homogenized [OPG study]4.0997620
GSM549116patient 072, normal, homogenized [OPG study]3.8160511
GSM549120patient 078, normal, homogenized [OPG study]3.923314
GSM549131patient 030, cancer, homogenized [OPG study]3.8135112
GSM549118patient 074, normal, homogenized [OPG study]4.5054229
GSM549129patient 027, cancer, homogenized [OPG study]3.9005313
GSM549123patient 088, normal, homogenized [OPG study]4.0301317
GSM549124patient 006, cancer, homogenized [OPG study]3.7906310
GSM549126patient 015, cancer, homogenized [OPG study]3.718859
GSM549128patient 025, cancer, homogenized [OPG study]6.5715166
GSM549103patient 117, normal, homogenized [OPG study]3.8233510
GSM549117patient 073, normal, homogenized [OPG study]3.707998
GSM549138patient 041, cancer, homogenized [OPG study]5.2411945
GSM549141patient 045, cancer, homogenized [OPG study]3.9335216
GSM549130patient 028, cancer, homogenized [OPG study]3.8509112
GSM549101patient 111, normal, homogenized [OPG study]3.8240411
GSM549105patient 128, normal, homogenized [OPG study]3.752259
GSM549106patient 134, normal, homogenized [OPG study]10.488395
GSM549112patient 048, normal, homogenized [OPG study]3.8807313
GSM549125patient 011, cancer, homogenized [OPG study]3.8118911
GSM549127patient 024, cancer, homogenized [OPG study]6.4513264
GSM549135patient 035, cancer, homogenized [OPG study]3.597156